subscribe

Save the Date: 2025 Donald G. Doehring Memorial Lecture

Thursday March 27th 2025 • 4:30pm to 6pm Leacock Building #232, 855 Sherbrooke West

Lori Leibold Ph.D. Senior Director • Center for Hearing Research

Speaker Bio

Published: 3 Feb 2025

Fourteen McGillians appointed to the Order of Canada

Governor General recognizes McGill community members for exceptional accomplishments and service

Fourteen members of the McGill University community have been appointed to the Order of Canada, one of the country’s highest civilian honours.  

Among the honourees are the University’s Chancellor and three professors: 

Published: 18 Dec 2024

An open solution to improving research reproducibility

Academic and industry scientists collaborate on a new method to characterize research antibodies

Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in collaboration with scientists from 11 major antibody manufacturers representing approximately 80 per cent of global renewable antibody production, have developed and standardized an Open Science platform to characterize research antibodies.

Published: 18 Dec 2024

Quebec government awards $1.6 million to McGill researchers providing innovative solutions for industry

McGill-led projects in genomics, imaging, and manufacturing serve businesses across Quebec 

Published: 16 Dec 2024

Prix Grands Sages honours McGill professor emeritus Dr. Phil Gold and two PhD candidates

Researchers’ outstanding contributions to science and society celebrated by the Fonds de recherche du Québec

Published: 14 Nov 2024

Fifteen new or renewed Canada Research Chairs awarded to McGill

$13.8 million in federal funding for McGill’s cohort of 10 new, five renewed Canada Research Chairs 

Published: 14 Nov 2024

Open Science project funded for $1.5M

YCharOS antibody characterization platform addresses the “reproducibility crisis” in research

An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.

YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.

Published: 12 Nov 2024

At-home neurological disorder diagnosis project receives major funding

$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s disease

REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.

Published: 8 Nov 2024

FREE Hearing Screening

No apppointment needed.

First come, first serve.

 

Thank you

Published: 4 Nov 2024

Caring Conversations - Home care or care home?

Caring Conversations is an online forum for care partners of people living with dementia to learn from experts, share concerns and ask questions.

Published: 31 Oct 2024

McGill researchers’ studies offer promise for lung and brain cancer treatment

Two seminal studies from McGill University, investigating immune landscapes of lung and brain tumours, were published today in Nature. This work was led by Logan Walsh, Daniela Quail and Peter Siegel, researchers at the Rosalind and Morris Goodman Cancer Institute and Philippe Joubert from Université Laval.

Email address:
Published: 2 Feb 2023

Message from VP-Dean Eidelman - The Faculty's Return to Campus

Dear Faculty of Medicine and Health Sciences Colleagues,

Published: 30 Jun 2021

Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada

Vancouver, BC -- The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Marathon of Hope Cancer Centres Network to begin operating.

Published: 9 Jun 2021

McGill researcher-led International Task Force unveils first-of-its kind standards for treatment of obsessive-compulsive disorder

By David McFadden

Listed by the World Health Organization among the ten leading causes of medical disability worldwide, the severity of obsessive-compulsive disorder (OCD) is at a level on par with cancer.  This prevalent disorder is characterized by highly distressing intrusive thoughts and repeated compulsive behaviours such as washing or checking.

Published: 3 Jun 2021

Two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy

A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy

Source: RI-MUHC

Published: 3 Jun 2021

Pages

Back to top